Lufthansa Cargo reduces freighter flights as voluntary pilot 'pandemic overtime' ends
Lufthansa Cargo has had to cut between 3% and 5% of its freighter flights after ...
JAS Worldwide has appointed David Bang (pictured above) as its executive vice president of global pharma & healthcare.
Mr Bang has over 20 years’ experience in logistics, supply chain, healthcare and the life sciences industries in various leadership positions including as co-founder of LifeConEx in 2005, a joint-venture between DHL and Lufthansa Airlines for bio-pharma international logistics. He became CEO of LifeConEx the following year and expanded the network to more than 100 stations in 65 countries.
Most recently, he was global vice president of strategic development for Hellmann, has also served as a board member of patient safety and product integrity advocacy group Rx-360 and a board member at MaxQ Research.
“David’s extensive accomplishments and leadership in the pharmaceutical and healthcare sectors, along with his vision and passion for developing programs that deliver value to pharma and healthcare manufacturers and distributors, makes him the perfect candidate to build and lead this vertical,” said JAS chief commercial officer Carol Kijac.
CEO Marco Rebuffi added: “JAS will be making significant investments in resources, infrastructure and product development in this vertical and with David at the helm, we are confident we will have a strong, compliant service offering to support clients in this vertical.”